MEDP vs. SWAV

Last updated Apr 1, 2026

Compare and contrast key facts about Medpace Holdings, Inc. (MEDP) and ShockWave Medical, Inc. (SWAV).

Performance

MEDP vs. SWAV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medpace Holdings, Inc. (MEDP) and ShockWave Medical, Inc. (SWAV). The values are adjusted to include any dividend payments, if applicable.

MEDP vs. SWAV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
MEDP Medpace Holdings, Inc.	-14.50%	69.05%	8.38%	44.31%	-2.40%	56.35%	65.60%	63.48%
SWAV ShockWave Medical, Inc.	0.00%	0.00%	75.67%	-7.32%	15.30%	71.93%	136.16%	44.00%

Fundamentals

Total Revenue (TTM) MEDP : $2.53B SWAV : $787.97M
Gross Profit (TTM) MEDP : $760.62M SWAV : $685.44M
EBITDA (TTM) MEDP : $541.22M SWAV : $204.51M

Returns By Period

MEDP

• 1D: 4.32%
• 1M: 6.29%
• YTD: -14.50%
• 6M: -6.61%
• 1Y: 57.60%
• 3Y*: 36.68%
• 5Y*: 23.13%
• 10Y*: —

SWAV

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

MEDP vs. SWAV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDP

MEDP Risk / Return Rank: 77
MEDP Sharpe Ratio Rank: 71
MEDP Sortino Ratio Rank: 82
MEDP Omega Ratio Rank: 82
MEDP Calmar Ratio Rank: 74
MEDP Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDP vs. SWAV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and ShockWave Medical, Inc. (SWAV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MEDP	SWAV	Difference
Sharpe ratio Return per unit of total volatility	0.85	—	—
Sortino ratio Return per unit of downside risk	2.18	—	—
Omega ratio Gain probability vs. loss probability	1.30	—	—
Calmar ratio Return relative to maximum drawdown	1.63	—	—
Martin ratio Return relative to average drawdown	4.82	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	MEDP	SWAV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.85	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.46	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.70	—	—

Correlation

The correlation between MEDP and SWAV is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MEDP vs. SWAV - Dividend Comparison

Neither MEDP nor SWAV has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	MEDP	SWAV	Difference
Max Drawdown Largest peak-to-trough decline	-42.87%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-32.96%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-42.87%	—	—
Current Drawdown Current decline from peak	-22.62%	—	—
Average Drawdown Average peak-to-trough decline	-12.64%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	11.14%	—	—

Volatility

Volatility by Period

	MEDP	SWAV	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.00%	—	—
Volatility (6M) Calculated over the trailing 6-month period	29.67%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	67.80%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.92%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.58%	—	—

Financials